To the Editor,
I have read with great interest the study entitled, “Evaluation of Tp-e Interval, Tp-e/QT Ratio and Tp-e/QTc Ratio in Patients with Mitral Valve Stenosis Before and After Balloon Valvuloplasty” (1). The authors demonstrated that Tp-e interval and Tp-e/QT and Tp-e/QTc ratios were prolonged in patients with mitral stenosis compared with healthy subjects and these parameters were favorably affected by percutaneous mitral balloon valvuloplasty (PMBV) even 24 h after the procedure. In addition, they affirmed that the link between ventricular repolarization abnormality, mitral stenosis, and effects of PMBV was sympathetic activation. Improvement seen in these arrhythmic markers in such short time and limited number of patients is striking and may be debatable. Similar to the present study, Özdemir et al. (2) showed that heart rate variability indices improved 1 day after PBMV. However, in another study, Ashino et al. (3) showed a reduction in sympathetic activity measured by muscle sympathetic activity in patients with mitral stenosis at 1 week after PBMV. Similarly, Yuasa et al. (4) demonstrated that muscle sympathetic nerve activity attenuated and cardiopulmonary baroreflex sensitivity improved 1 week after PBMV in patients with mitral stenosis. In the studies in which sympathetic activity is evaluated 1 week after PMBV, significant changes in electrocardiographic parameters just 1 day after PMBV seem to be too early. I believe that it would be more accurate and valuable if a sympathetic activity marker is measured and analyzed to determine significant correlations with electro- and echocardiographic parameters before and after the procedure.
In conclusion, this study can be a source of inspiration for further research in patients with aortic stenosis treated with transcatheter aortic valve implantation and hypertrophic cardiomyopathy treated with septal ablation because of similar mechanisms.
References
- 1.Dural M, Mert KU, İskenderov K. Evaluation of Tp-e interval, Tp-e/QT ratio and Tp-e/QTc ratio in patients with mitral valve stenosis before and after balloon valvuloplasty. Anatol J Cardiol. 2017;18:353–60. doi: 10.14744/AnatolJCardiol.2017.7876. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Özdemir O, Alyan O, Soylu M, Metin F, Kaçmaz F, Demir AD, et al. Improvement in sympatho-vagal imbalance and heart rate variability in patients with mitral stenosis after percutaneous balloon commissurotomy. Europace. 2005;7:204–10. doi: 10.1016/j.eupc.2005.02.088. [DOI] [PubMed] [Google Scholar]
- 3.Ashino K, Gotoh E, Sumita S, Moriya A, Ishii M. Percutaneous transluminal mitral valvuloplasty normalizes baroreflex sensitivity and sympathetic activity in patients with mitral stenosis. Circulation. 1997;96:3443–9. doi: 10.1161/01.cir.96.10.3443. [DOI] [PubMed] [Google Scholar]
- 4.Yuasa T, Takata S, Terasaki T, Kontani M, Saito S, Nagai H, et al. Percutaneous transluminal mitral valvuloplasty improves cardiopulmonary baroreflex sensitivity in patients with mitral stenosis. Auton Neurosci. 2001;94:117–24. doi: 10.1016/s1566-0702(01)00334-4. [DOI] [PubMed] [Google Scholar]